Bupropion hydrochloride
- Product NDC
- 71335-2496
- 11-digit product format
- 713352496
- Labeler code
- 71335
- Product ID
- 71335-2496_6651e74d-5691-474c-819d-950ea238be85
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Bupropion hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA216800
- Marketing category
- ANDA
- Marketing start
- 2023-05-31
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| ZG7E5POY8O | BUPROPION HYDROCHLORIDE | 31677-93-7 | BUPROPION HYDROCHLORIDE |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 71335-2496-1 | 71335249601 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2496-1) | 2024-09-16 | No | No | Historical |
| 71335-2496-2 | 71335249602 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2496-2) | 2024-09-16 | No | No | Historical |
| 71335-2496-3 | 71335249603 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2496-3) | 2024-09-16 | No | No | Historical |
| 71335-2496-4 | 71335249604 | 45 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2496-4) | 2024-09-16 | No | No | Historical |
| 71335-2496-5 | 71335249605 | 28 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2496-5) | 2024-09-16 | No | No | Historical |
| 71335-2496-6 | 71335249606 | 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2496-6) | 2024-09-16 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Bupropion hydrochloride | Bryant Ranch Prepack | 2024-09-16 | HUMAN PRESCRIPTION DRUG LABEL | 1 |